FIELD: medicine. SUBSTANCE: method involves administering dihydroergotamine mezylate in tablets at a dose of 2.5 mg twice a day during 30 days to patients having psychogenous erectile dysfunction caused by increased catecholamine contents in peripheral blood determined during masturbation and after ejaculation. EFFECT: prolonged treatment effectiveness.
Authors
Dates
2001-01-27—Published
1999-11-23—Filed